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Although the product of the UL12 gene of herpes simplex virus type 1 (HSV-1) has been shown to possess both
exonuclease and endonuclease activities in vitro, and deletion of most of the gene within the viral genome results in
inefficient production and maturation of infectious virions, the function of the deoxyribonuclease (DNase) activity per se in
virus replication remains unclear. In order to correlate the in vitro and in vivo activities of the protein encoded by UL12, mutant
proteins were tested for nuclease activity in vitro by a novel hypersensitivity cleavage assay and for their ability to
complement the replication of a DNase null mutant, AN-1. Rabbit reticulocyte lysates programmed with wild-type UL12 RNA
cleaved at the same sites cleaved by purified HSV-1 DNase, but distinct from those cleaved by DNase I or micrococcal
nuclease. All mutants which lacked DNase activity in vitro also failed to complement the replication of AN-1 in nonpermissive
cells. Likewise, all mutants which contained HSV-1 DNase activity, as detected by the hypersensitivity cleavage assay, were
capable of complementing the replication of the DNase null mutant, though to varying extents. Of particular note was the
d1-126 mutant protein, which, despite having the same specific activity as the wild-type enzyme in vitro, complemented the
replication of AN-1 significantly less than the wild-type protein. The results suggest that DNase activity per se is required for
efficient replication of HSV-1 in vivo. However, residues, including the N-terminal 126 amino acids, which are dispensable for
enzymatic activity in vitro may facilitate the accessibility or activity of the protein in vivo. © 1998 Academic Press
INTRODUCTION
Herpes simplex virus type 1 (HSV-1) encodes a de-
oxyribonuclease (DNase) which has been reported to
possess both endonuclease (endo) and exonuclease
(exo) activities with an alkaline pH optimum (Hoffmann
and Cheng, 1978, 1979; Hoffmann, 1981; Banks et al.,
1983; Shao et al., 1993). The gene encoding the HSV-1
DNase has been mapped to the UL12 open reading
frame (ORF) (Draper et al., 1986; McGeoch et al., 1986,
1988), which is predicted to encode a protein containing
626 amino acids. Despite extensive studies to charac-
terize the enzymatic activity of the DNase purified from
HSV-infected cells (Hoffmann and Cheng, 1978, 1979;
Strobel-Fidler and Francke, 1980; Hoffmann, 1981; Banks
et al., 1983), the actual in vivo function of the protein is
not known. The isolation of a DNase null mutant capable
of replicating in Vero cells, albeit less efficiently than the
wild-type virus (Weller et al., 1990), indicates that the
gene is not absolutely essential for virus replication, at
least in some tissue culture cells.
Interestingly, some HSV DNase mutant isolates have
been shown to synthesize less than wild-type levels of
DNA, particularly at low input multiplicity (Shao et al.,
1993). The HSV DNase has been shown to be associated
with some of the viral proteins involved in DNA replica-
tion, most notably the major DNA-binding protein, in-
fected cell protein 8 (ICP8; Littler et al., 1983; Thomas et
al., 1988; Turco and Pignatti, 1988; Thomas et al., 1992).
Therefore, the DNase may play an indirect role in viral
DNA synthesis under certain conditions or may utilize
DNA replication proteins for other functions.
In nonpermissive cells infected with AN-1, the presence
of an abundance of defective A capsids in the nucleus,
coupled with a defect in nuclear egress of apparently com-
plete capsids, suggests that the enzyme might be involved
in the processing of DNA into capsids (Shao et al., 1993).
Although nuclear AN-1 DNA contains more complex and
branched structures resembling recombinational interme-
diates than does wild-type DNA, a postulated role for the
DNase in recombination was recently excluded (Martinez
et al., 1996a). Thus, it remains unclear whether or how the
enzymatic activity of the UL12 protein affects viral replica-
tion and DNA processing.
Because AN-1 deletes a large portion of the UL12 gene,
it is possible that functions unrelated or in addition to the
nuclease activity of the protein are important for replication.
Therefore, we have begun to analyze the domains of the
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protein required for nuclease activity by more selective
mutagenesis of the UL12 gene and to determine the ability
of DNase mutant proteins to provide important replication
functions. To this end, we have developed an assay to
measure the enzymatic activity of in vitro translation prod-
ucts of wild-type and mutant HSV-1 DNase genes. Our
results demonstrate that the N-terminal 126 amino acids of
the gene, a region which is not conserved among the
herpesviruses, is completely dispensable for specific nu-
clease activity, while the conserved C-terminus is essential.
Moreover, correlation of the in vitro enzymatic activity of
UL12 mutant proteins, with their ability to complement the
replication of the AN-1 null mutant, suggests that the nu-
clease activity per se of the UL12 protein provides an
important replication function.
RESULTS
Hypersensitivity cleavage assays
The product of the UL12 gene of HSV-1, often denoted
alkaline exonuclease, has been reported to possess
endo and 59–39 exo activities under a variety of condi-
tions (Hoffmann and Cheng, 1978, 1979; Strobel-Fidler
and Francke, 1980; Hoffmann, 1981; Banks et al., 1983;
Knopf and Weisshart, 1990). Therefore, throughout this
report, the more generic term, deoxyribonuclease
(DNase), will be used to describe the enzymatic activity
of the UL12 gene product. We were interested in devel-
oping a rapid and sensitive method to measure the
activities of wild-type or mutant DNase expressed by in
vitro translation (Fig. 1). To provide a standard for these
comparisons, we purified authentic HSV-1 DNase from
BHK cells infected with the wild-type strain KOS. Be-
cause the viral-encoded DNA polymerase (pol) and its
associated processivity factor, UL42, copurify with the
DNase throughout most of the published purification
schemes (Hoffmann and Cheng, 1978; Gallo et al., 1988;
Knopf and Weisshart, 1990), and in view of the fact that
pol and pol:UL42 possess 39–59 exo activity (Knopf, 1979;
O’Donnell et al., 1987; Knopf and Weisshart, 1990; Marcy
et al., 1990), we developed a method to completely re-
move these proteins from our standard preparations of
HSV-1 DNase.
We previously demonstrated that pol and UL42 copu-
rified with the DNase when nuclear extracts of infected
cells were fractionated first through DEAE–Sephacel and
then blue Sepharose columns, but the DNase was pre-
dominantly separated from pol and UL42 by subsequent
passage over a Mono Q column (Gallo et al., 1988). The
trace levels of pol and UL42 were completely removed
from the DNase-containing Mono Q fractions after chro-
matography over a Mono S column, as demonstrated by
FIG. 1. Summary of structures of wild-type and UL12 mutant genes. Plasmid pTZ DN8, containing the HSV-1 UL12 (DNase) ORF downstream of the
T7 RNA polymerase promoter, was used as the parental plasmid from which C-terminal truncations were generated, while pTZDN8/Hind III2, which
lacks the C-terminal HindIII site, was used to generate the N-terminal truncations indicated. The top line indicates the size in kilobase pairs of the
region studied. The second line displays the positions of relevant restriction enzyme cleavage sites used for cleavage within the ORF and for cloning
(Bg, BglII; H, HindIII; N, NcoI; Pv, PvuI; S, SphI; Xo, XhoI; Xb, XbaI). The large arrows below depict the sequences corresponding to the DNase ORF,
encoding the wild-type (WT) protein of 626 amino acids, and to the mutated DNase ORFs used in this study. The relative positions of primers used
to create the d1-126 plasmid are shown with the top line. Although the primers are not drawn to scale, the location of the first matched 59 proximal
nucleotide of each primer is accurately depicted. A similar method was used to create d2-148. Transcripts for the production of the WT and mutant
proteins shown were generated by cleavage with XbaI downstream of the ORF.
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the lack of reactivity to a monoclonal antibody to UL42
and by the lack of detectable pol activity in the peak
DNase-containing fractions from the column (data not
shown). The purity of these fractions also is demon-
strated by the silver-stained SDS–polyacrylamide gel
profile in Fig. 2A. Fraction 23, which contained most of
the DNase activity, also contained the most protein (Fig.
2A, lane 2) and was used in all subsequent experiments.
The stained profile displays a primary band migrating
with an apparent molecular weight of 89,000, in agree-
ment with the migration of purified HSV-1 DNase as
previously reported (Strobel-Fidler and Francke, 1980;
Banks et al., 1983; and Costa et al., 1983). The profile also
demonstrates a clear absence of polypeptide migrating
at the position expected for pol (140,000). Although the
major band is reactive to antibody prepared against a
C-terminal DNase peptide (Fig. 2B), the minor, faster
migrating bands most likely represent proteolytic degra-
dation products consisting of the N-terminus of the
DNase or products which exist in very small amounts,
since they were not detectable by Western blotting using
this antibody.
Mono S fraction 23 and a commercial preparation of
bovine DNase I were used to partially digest a double-
stranded DNA fragment labeled at a single 39 end, and
the cleavage products were analyzed by electrophoresis
through denaturing sequence-style gels as described
under Materials and Methods. Figure 3A illustrates the
major cleavage products of the labeled strand following
digestion of the DNA fragment with purified HSV-1
DNase for increasing periods of time. During short peri-
ods of incubation, several large fragments were pro-
duced, indicative of cleavage at sites hypersensitive to
the HSV-1 DNase (Fig. 3A, lane 1). Additional hypersen-
sitive sites were evident after longer periods of incuba-
tion by the appearance of smaller fragments (Fig. 3A,
lanes 2 and 3). That the initial products formed in the
presence of the HSV-1 DNase are due to endonucleolytic
cleavage at hypersensitive sites, rather than to pausing
of the enzyme at hyperresistant sites during exo degra-
dation, is suggested by the production of the same frag-
ments in the presence of 5 mM MnCl2 (results not
shown), which dramatically inhibits the 59 to 39 exo ac-
tivity and favors endo-specific cleavages (Hoffmann and
Cheng, 1979). In addition, large DNA fragments were
produced following short incubation times with DNA sub-
strates which were labeled at the 59 end, precluding their
formation as a result of 59 to 39 exo activity (results not
shown). However, we cannot exclude the possibility that
some of the fragments evident upon extended incubation
of the DNA substrate with the HSV-1 DNase may have
resulted from pausing of the exo activity at certain sites,
since both endo and exo activities were present under
the reaction conditions used in this experiment.
Most of the sites hypersensitive to cleavage by the
HSV-1 DNase (Fig. 3A, small arrows) were clearly distin-
guishable from those cleaved by another endo activity,
bovine DNase I—only two sites (Fig. 3A; denoted by
small circles) were hypersensitive to cleavage by both
enzymes. Thus, the HSV-1 DNase recognizes sequences
and/or conformation of the DNA substrate differently
than does DNase I. These results suggested to us that
the pattern of cleavage might be a good tool for measur-
FIG. 2. SDS–PAGE of purified and in vitro-translated HSV-1 DNase. (A) Silver staining pattern of the Mono S fractions which contained the peak
DNase activities, following purification of HSV-1-infected cell nuclear extracts as described. Samples were electrophoresed through a denaturing
10–20% polyacrylamide gel. (B) An autoradiogram of a Western blot of Mono S fraction 23 (lane 1) and in vitro translation products following
SDS–PAGE separation. In vitro translation (IVT) products from unprogrammed reticulocyte lysates (lane 2) or wild-type (WT) UL12 RNA (lane 3) were
synthesized in the presence of [35S]methionine. Proteins transferred to nitrocellulose were immunoblotted with antibody 319A, specific for the HSV-1
DNase. The autoradiogram shown exhibits the dual 125I and 35S signals, since there was insufficient protein present in the IVT products to yield a
detectable signal by immunoblotting.
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ing HSV-1 DNase activity in less purified preparations,
such as in vitro translation products.
Activity of HSV-1 DNase expressed by in vitro
translation
To test this hypothesis, we generated transcripts in
vitro from a plasmid containing the wild-type HSV-1 UL12
gene cloned downstream of a T7 promoter and trans-
lated the RNA in rabbit reticulocyte lysates (RRL). The
translated product was consistently observed to migrate
slightly faster than the purified DNase (Fig. 2B, compare
lane 3 with lane 1), most likely due to lack of phosphor-
ylation in the translated product (J. Henderson and D.
Parris, unpublished results). The products of cleavage of
the labeled DNA fragment by purified HSV-1 DNase were
compared with those produced by cleavage with the
programmed RRL. To control for the presence of nucle-
ases in the RRL, we also cleaved the DNA substrate with
unprogrammed RRL. Although most of the DNA substrate
remained uncleaved following incubation with unpro-
grammed RRL for 30 min (Fig. 3B, lane 8), a low level of
contaminating nuclease was evidenced by the appear-
ance of two large fragments (Fig. 3B, open arrowheads),
not detectable by incubation of the DNA substrate with-
out enzyme (Fig. 3B, lane 1). These products were clearly
distinct from those produced by incubation of the DNA
substrate with RRL programmed with wild-type UL12
transcripts (Fig. 3B, lane 3). After 30 min, most of the
substrate had been cleaved at least once by HSV-1
DNase translation products and sites hypersensitive to
cleavage were detected by the presence of distinct DNA
fragments. Interestingly, the pattern of fragments pro-
duced by the HSV-1 DNase gene translated in vitro was
nearly identical to that produced by cleavage with puri-
fied HSV-1 DNase (Fig. 3B, compare lane 3 with lane 2).
That the minor differences observed were quantitative
rather than qualitative and due to the presence of more
enzymatic activity in the reactions containing RRL pro-
grammed with the wild-type HSV-1 DNase transcripts
than in reactions containing the purified enzyme is sup-
ported by two observations. First, less intact DNA sub-
strate remained following cleavage with the in vitro
translation products compared to that remaining after
cleavage with the amount of purified enzyme used. Sec-
ond, those bands which are more or less prominent in
reactions containing the in vitro translation products are
the same fragments which are more or less prominent,
respectively, following incubation of DNA substrate for
increasing amounts of time with a constant amount of
enzyme (Fig. 4). Taken together, these results demon-
strate that nuclease activity specifically attributable to
the HSV-1 DNase encoded by UL12 can be distinguished
in programmed RRL, providing a ready means to assay
the enzyme activities of various mutant forms of the viral
DNase.
Activities of HSV-1 DNase mutant proteins
C-terminal deletions of the UL12 gene, cloned in a T7
transcription vector, were prepared by linearizing the
plasmid within the ORF, followed by generation of run-off
FIG. 3. Detection of sites hypersensitive to nuclease cleavage. A 176-bp DNA fragment was labeled at a single 39 end and subjected to cleavage
by samples containing various nuclease activities. The products were purified, separated by electrophoresis through denaturing sequencing gels, and
autoradiographed as described under Materials and Methods. (A) The DNA substrate was incubated with purified HSV-1 DNase for 1, 5, and 15 min
(lanes 1–3). In lanes 4–8, the DNA substrate was incubated for 15 min without enzyme (lane 4) or with inverse dilutions of bovine pancrease DNase
I (126 U/ml) as indicated (lanes 5–8). The large bold arrow at the top of the gel indicates the uncleaved DNA substrate, the smaller arrows indicate
bands produced by cleavage at sites specifically hypersensitive to the HSV-1 DNase, and the dots correspond to bands in common between those
produced by HSV-1 DNase and the DNase I. (B) Comparison of cleavage products produced by 30 min incubation with purified HSV-1 DNase (lane
2) or in vitro-translated wild-type UL12 (lane 3) or C-terminal truncations of UL12 RNA (lanes 4–7). As negative controls, DNA was incubated without
enzyme (lane 1) or with unprogrammed rabbit reticulocyte lysates (lane 8) using the same reaction conditions. Arrows and dots are as indicated in
A. Open arrowheads denote cleavage products produced by incubation with control rabbit reticulocyte lysates.
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transcripts with T7 RNA polymerase (Fig. 1). Transcripts
predicted to encode the N-terminal 566, 501, 374, or 179
amino acid residues of the HSV-1 DNase were translated
in vitro in RRL as described above and tested for their
ability to cleave the uniquely end-labeled DNA substrate.
The products produced by digestion with each of the
C-terminally truncated proteins were indistinguishable
from those produced by incubation with unprogrammed
RRL (Fig. 3B, compare lanes 4–7 with lane 8), and none
of the fragments diagnostic for HSV-1 DNase activity
(lane 3) were present. A C-terminal truncation mutant
(N577) was constructed by the substitution of a stop
codon at position 578 and this mutant protein also lacked
detectable HSV-1 nuclease activity by this assay (Table
2). We confirmed that all proteins were translated effi-
ciently and were stable under the assay conditions (re-
sults not shown), indicating that the failure to cleave the
DNA substrate was due to an inherent loss of activity of
the mutant proteins. Moreover, failure of the N577 mutant
to cleave the DNA was not due to insolubility since
greater than 50% of the N577 protein was found in the
supernatant fraction following two 100,000g centrifuga-
tion steps (results not shown). Taken together, these
results demonstrate that the C-terminal 49 amino acids
of the DNase are essential for cleavage of DNA in vitro
under the assay conditions we employed.
In order to determine the N-terminal residues required
for in vitro activity, several deletion mutations in the UL12
ORF were introduced by PCR as described under Mate-
rials and Methods and Table 1. The ability of the trans-
FIG. 4. Nuclease activity of N-terminal deletion mutants. Cleavage of
DNA by unprogrammed rabbit reticulocyte lysates (H2O) or in vitro
translation products of wild-type or N-terminal truncations of UL12 RNA
was conducted as described in the legend to Fig. 3 except that 2 ml of
a 1:2 dilution of rabbit reticulocyte mixtures was used to initiate nucle-
ase reactions. DNA incubated without the addition of translation mix-
tures for 40 min is shown in lane 14. Otherwise reactions were stopped
at the times indicated. The large arrow at the top of the gel denotes
uncleaved DNA substrate.
TABLE 1
Construction of UL12 Mutants by PCR
Mutant Mutagenesis method Primer Oligonucleotidea Primer description Fragment cloned
d1-126 2-step PCR 1 gagcgaggaagcggaagagcgcccaata 59 of HindIII HindIII–XhoI
2 ATCACCGACGCCGACCAcatttccgagacgacgt Noncontiguous
3 ACGTCGTCTCGGAAATGtggtcggcgtcggtgat Noncontiguous
4 cgcaggctggcgttgtgcttca 39 of XhoI
d2-148 2-step PCR 5 cgagtcagtgagcgaggaagcggaagag 59 of HindIII HindIII–XhoI
6 AGCAACCCGCGAAGGTGcatttccgagacgacgt Noncontiguous
7 ACGTCGTCTCGGAAATGcacctgcgcgggttgct Noncontiguous
8 tacttggcccggcatttgacctcgtaaa 39 of XhoI
L150A 2-step PCR 9 tcctggtgctggtgtcccgcctgtgtca 59 of HpaI HpaI–XhoI
10 caacccgcgTGCgtggcgctcgaa Mutagenic
11 ttcgagcgccacGCAcgcgggttg Mutagenic
12 gaacggcctggttcgggagaa 39 of XhoI
L150K 2-step PCR 13 cggctcgtatgttgtgtggaa 59 of HindIII HindIII–XhoI
14 caacccgcgTTTgtggcgctcgaa Mutagenic
15 ttcgagcgccacAAAcgcgggttg Mutagenic
12 gaacggcctggttcgggagaa 39 of XhoI
Y371F 1-step PCR 16 cctggtgctggtgtcccgcctgtg 59 of XhoI XhoI–NcoI
17 gggtccatggggtcgaaagcgAActtgg Mutagenic/NcoI
Y371A 1-step PCR 16 cctggtgctggtgtcccgcctgtg 59 of XhoI XhoI–NcoI
18 gggtccatggggtcgaaagcCGCcttgg Mutagenic/NcoI
N577 1-step PCRb 19 ccgcatcgatTGAgagatcta Mutagenic/ClaI ClaI–XbaI
20 GCTCTAGAccgtccgccgttggta 39 of ORF/new XbaI site
a Lowercase letters are sequences in the primer homologous to the wild-type sequence. The altered nucleotides in mutagenic primers are
indicated by uppercase letters. For noncontiguous primers, the sequences which are noncontiguous in the first step of the PCR are in uppercase
letters. Restriction sites contained in primers and used for cloning are in boldface and underlined.
b Sequences were amplified from a derivative of plasmid pSG10 which contained the UL12 ORF and sequences downstream.
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lation products of two of these mutants and the wild-type
gene to cleave the DNA substrate is illustrated in Fig. 4.
Mutant HSV-1 DNase lacking the first 126 amino acid
residues (d1-126) produced the same DNA fragments as
the wild-type DNase. More enzyme activity was present
in the RRL programmed with the wild-type transcripts as
judged by less intact product remaining after 10 min of
incubation (Fig. 4, lane 4) compared to that remaining
after 10 min of cleavage with the d1-126 translation
products (Fig. 4, lane 5). However, there was a clear
progression of the appearance of hypersensitive sites
with increasing time of incubation for both the d1-126
and wild-type proteins and these sites were identical. By
contrast, protein lacking the N-terminal residues 2–148
failed to cleave DNA in the characteristic pattern pro-
duced by the full-length protein. Indeed, the cleavage
products of digestion by the d2-148 mutant protein were
identical to those produced by unprogrammed RRL, even
after 40 min of incubation (Fig. 4, compare lanes 12 and
13). Both mutant proteins were translated efficiently,
were stable under the assay conditions, and displayed
greater than 70% solubility after two 100,000g spins (not
shown).
Additional UL12 mutations were generated and tested
for their ability to encode proteins with enzymatic activity.
Table 2 summarizes the ability of in vitro translation
products of various mutant forms of UL12 to cleave the 39
end-labeled DNA substrate at the hypersensitive sites
characteristic of cleavage by the wild-type HSV-1 UL12
protein. Of particular note are the activities of proteins
mutated at residues 371 and 150. Although tyrosine 371
is completely conserved among 14 different herpesvirus
homologs (results not shown), it is not required for en-
zymatic activity in vitro. Furthermore, a conservative mu-
tation at residue 150 (L to A) allowed retention of nucle-
ase activity, whereas a nonconservative mutation at the
same site (L to K) destroyed in vitro activity.
The higher level of activity displayed by translation
products of the wild-type gene compared to those of the
d1-126 gene illustrated in Fig. 4 could have been due to
differences in the amounts of protein generated in the
RRL or differences in specific activity of the proteins. In
order to compare the specific activities of the wild-type
and d1-126 proteins, we translated the proteins in RRL in
TABLE 2
Summary of Enzyme and Replication Activities
of UL12 Mutant Proteins
Mutant DNase activitya
Complementation of
AN-1 replicationb
(No. pos./No. exp.)
No plasmid 2 2 (0/7)
Vector (pTZ19U) NDc 2 (0/7)
pTZ DN8 (WT) 1 11 (7/7)
pTZ DN8/Hind III-(WT) 1 11 (6/6)
d373-375 1 11 (4/4)
d1-126 1 1 (6/6)
d2-148 2 2 (0/6)
Y371F 1 1 (6/6)
Y371A 1 1 (4/4)
L150A 1 1 (4/4)
L150K 2 2 (0/3)
N577 2 2 (0/4)
N566 2 ND
N501 2 ND
N374 2 ND
N159 2 ND
a Nuclease activity was determined by hypersensitivity cleavage
assay of in vitro transcription/translation products of the indicated
plasmids.
b For each experiment, four replicate BHK cultures were transfected
with the indicated test plasmid and superinfected with AN-1 (2.5 PFU/
cell) 25 h later. Cultures were harvested 18 h p.i. and the yield of
progeny was determined by plaque assay in permissive 6-5 cells.
Complementation indices were calculated as the number of plaques
produced for each replicate culture transfected with the test plasmid
divided by the average number of plaques produced by transfection
with pTZ DN8 in that experiment times 100. Positive complementation
was defined as a complementation index significantly greater (P , 0.05
by two-tailed t test) than that with the pTZ19U vector or no plasmid
controls. A score of 11 indicates that there was no significant differ-
ence in complementation indices for the test plasmid and wild-type
plasmid pTZDN8. In the seven experiments scored above, the mean
complementation indices 6 standard deviation for controls were as
follows: pTZ DN8: 100 6 24, 100 6 17, 100 6 17, 100 6 17, 100 6 33,
100 6 14, 100 6 14; pTZ 19U: 1.6 6 1.4, 6.1 6 1.0, 16 6 4.0, 2.8 6 0.4,
14 6 1.5, 16 6 1.0, 2.9 6 0.7; no plasmid: 3.9 6 1.1, 8.9 6 1.0, 12.0 6 3.0,
2.2 6 0.3, 8.0 6 1.0, 18 6 6.0, 1.9 6 0.2.
c Not determined.
FIG. 5. Relative specific activities of the wild-type and d1-126 en-
zymes. Unprogrammed RRL () or RRLs programmed with wild-type
(h) or d1-126 (F) RNA in the presence of [35S]methionine were treated
with EGTA and diluted 1:20 prior to incubation with the labeled DNA
substrate for various times. Products were analyzed by denaturing gel
electrophoresis and the amount of radioactivity remaining in the un-
cleaved substrate was quantified by phosphorimager analysis.
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the presence of [35S]methionine. The activity of the en-
zyme present was measured by the loss of intact DNA
substrate over time, and the level of labeled HSV-1
DNase protein (adjusted for methionine content) was
determined by quantitation of the radioactivity present in
the DNase bands following SDS–PAGE of a portion of the
diluted RRL used for each enzymatic assay. Figure 5
shows the time course for cleavage, prior to correction
for protein content, of the labeled DNA substrate by
unprogrammed RRL or RRL programmed with wild-type
or d1-126 RNA. To reduce even further the small amount
of cleavage previously observed by unprogrammed RRL,
reactions employed EGTA to inhibit the residual micro-
coccal nuclease activity present in most commercial
batches of RRL. Indeed, under these conditions, we ob-
served very little degradation of the substrate over time
with unprogrammed RRL (Fig. 5). RRL programmed with
the d1-126 transcripts cleaved at a rate of 0.28 fmol/min,
while RRL programmed with the wild-type transcripts
cleaved at a rate of 0.41 fmol/min. Based upon phor-
phorimager quantitation, 1.27-fold more wild-type than
d1-126 protein was present in the RRL (not shown). Thus
the rate of degradation by the wild-type protein, when
adjusted for protein content, was 0.32 fmol/min, in excel-
lent agreement with the rate observed for the mutant
protein. We conclude that DNase activity of the UL12
protein deleted for the first 126 amino acids is indistin-
guishable both qualitatively and quantitatively from the
wild-type protein under the in vitro assay conditions we
employed. Moreover, deletion of only 22 additional resi-
dues from the N-terminus completely abrogated the en-
zymatic activity in vitro.
Complementation of a DNase null mutant
The relationship between the nuclease activity of the
DNase detected in vitro and the exact role of the UL12
protein in the replication of HSV-1 has not been fully
assessed. However, it is clear that deletion of the UL12
gene dramatically impairs the production of infectious
progeny virions, though UL12 null mutants can produce
some infectious virions in ‘‘nonpermissive’’ Vero cells
(Weller et al., 1990). In an effort to more fully understand
the role of the nuclease activity per se in the replication
of HSV-1, we tested the ability of plasmids, encoding the
wild-type or various mutant UL12 genes, to complement
the replication of the DNase null mutant AN-1 in nonper-
missive BHK cells. These cells were selected because
the yield of progeny of AN-1 in single-step growth exper-
iments was lower than that in Vero cells and because of
their higher transfection efficiency (not shown). BHK cells
were transfected with 10 mg of the appropriate plasmid
by the calcium phosphate method followed by superin-
fection with AN-1. Yields of progeny were determined
after a single replication cycle (18 h p.i. at 34°C), and the
combined extracellular and intracellular yield for each
sample was determined by plaque assay on permissive
6-5 cells, which express UL12 in trans. A representative
experiment in which four replicate transfections for each
plasmid were tested for complementation of AN-1 is
shown in Fig. 6. At least three independent experiments
were performed for each mutant (four replicates per
mutant for each experiment) and the results are summa-
rized in Table 2. Complementation indices were deter-
mined as previously described (Reddig et al., 1994) and
represented the percentage of virus yield in transfections
with test plasmids compared to the yield with the wild-
type plasmid, pTZDN8. Plasmids were scored as positive
for complementation when the complementation index
with the test plasmid was significantly greater (P , 0.05
by two-tailed t test) than that with empty or no vector.
Though we observed variability in the absolute virus
yields obtained among different experiments, perhaps as
a result of transfection efficiency differences and/or dif-
ferences in plasmid expression, plasmids consistently
complemented or failed to complement by this criterion
(Table 2).
The wild-type plasmid pTZDN8 increased the produc-
tion of progeny AN-1 approximately 12-fold compared to
FIG. 6. Complementation of the replication of HSV-1 DNase null
mutant AN-1 by UL12 mutant plasmids. BHK cells in 60-mm dishes
were transfected with 10 mg of the indicated plasmid or carrier DNA
control using the calcium phosphate method. Twenty-five hours later,
cells were superinfected with AN-1 (2.5 PFU/cell) at 34°C, and unad-
sorbed virus was removed 1 h later with an acid–glycine wash. Cells
were incubated at 34°C and harvested at 18 h p.i., and the total yield of
infectious progeny virus from each culture was determined by plaque
assay in permissive 6-5 cells. A representative experiment which in-
cluded four replicate cultures for each DNA tested is shown. Bars show
the mean number of progeny/culture with standard deviation. Three to
seven independent experiments for each plasmid have been con-
ducted with similar results.
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empty plasmid vector or carrier DNA transfection con-
trols (P , 0.001). That the increased virus yield was due
to complementation of AN-1 rather than increased via-
bility of a recombinant virus was confirmed by the ab-
sence of large plaques when the yields were assayed on
nonpermissive Vero cells (data not shown).
The d2-148, L150K, and N577 plasmids, which specify
proteins lacking nuclease activity in vitro, also failed to
complement the replication of the DNase null mutant
(Table 2). By contrast, each mutant protein with nuclease
activity in vitro complemented the replication of AN-1,
though to varying degrees (Table 2). In each experiment
the d373-375 mutant plasmid produced AN-1 yields in-
distinguishable from those produced with the wild-type
plasmid (Table 2). However, in most of the experiments
for each of the other mutant genes encoding a functional
nuclease activity (d1-126, Y371F, Y371A, and L150A),
AN-1 yields were significantly less (P , 0.05) than those
produced with the wild-type plasmid (not shown). In each
of the six experiments in which it was included, the
d1-126 plasmid yielded the lowest complementation in-
dices which were scored as positive. Nevertheless, a
three- to fourfold enhancement of AN-1 replication was
observed in the presence of d1-126 plasmid, compared
to negative controls, in the majority of experiments per-
formed.
The decreased ability of some of these mutant pro-
teins to enhance replication compared to the wild-type
protein, despite comparable enzymatic activities in vitro
as observed for the d1-126 protein, could indicate that
the sequences deleted or mutated facilitate the function-
ing of the nuclease in infected cells. However, we cannot
rule out minor differences in the expression and/or sta-
bility of the mutant proteins as the cause for the ob-
served differences in replication. Nevertheless, our find-
ings of complete correlation between the ability of a
mutant gene to significantly complement the replication
of AN-1 in nonpermissive cells and the presence of
specific nuclease activity in vitro suggest that the func-
tion of the UL12 protein in the replication of HSV-1 is
related to its nuclease activity.
DISCUSSION
In vitro assay of enzymatic activity
A number of studies have characterized the biochem-
ical properties of the HSV-1 DNase purified from HSV-1-
infected cells or expressed by Escherichia coli (Hoff-
mann and Cheng, 1979; Strobel-Fidler and Francke, 1980;
Banks et al., 1983; Bronstein and Weber, 1996). However,
because the enzyme possesses both endo and 59–39 exo
activities, it has been difficult to study in less purified
preparations, a feature which has impeded the functional
analysis of mutant forms of the DNase. In this report, we
demonstrate the utility of a hypersensitivity cleavage
assay to qualitatively and quantitatively measure the
enzymatic activity of mutant forms of the HSV-1 DNase
expressed by in vitro transcription/translation. Our re-
sults demonstrate that the recognition of hypersensitive
sites on a given double-stranded DNA substrate by
HSV-1 DNase expressed in vitro in RRL does not differ
from that of the purified enzyme (Fig. 3B). Although the
DNase is phosphorylated in HSV-1-infected cells (Mars-
den et al., 1978; Wilcox et al., 1980; Preston and Cording-
ley, 1982; Banks et al., 1985; Thomas et al., 1988), it is not
phosphorylated in RRL (J.H. unpublished results), indicat-
ing that phosphorylation is not required for enzymatic
activity, at least in vitro. That the pattern of cleavage of
the purified and in vitro-translated enzyme is indistin-
guishable further confirms that no other viral gene prod-
uct is required for enzymatic activity in vitro. However,
our results do not rule out the possibility that protein–
protein interactions of the DNase with other viral or
cellular proteins may modulate its activity, either by di-
recting it to specific cleavage sites within the cell or by
modifying its enzymatic activity intracellularly.
Because of the nature of the assay, it is possible to
distinguish enzyme activity attributable to the HSV-1
DNase from many other nucleases. Our results demon-
strate that the hypersensitive sites recognized on a given
DNA substrate are distinct from those generated by two
other endonucleases with little sequence specificity—
DNase I (Fig. 2B) and micrococcal nuclease—the latter
of which is commonly found in commercial preparations
of RRL (Figs. 3B and 4). Although we have been able to
detect no discernable sequence-specificity for the rec-
ognition of hypersensitive sites by the HSV-1 DNase
(unpublished results), partial cleavage of a given DNA
substrate by the HSV-1 enzyme consistently reveals the
same hypersensitive sites. However, for optimum perfor-
mance of the assay, it was important to determine en-
zyme concentrations and time of incubation which yield
predominantly large cleavage products, since the initial
cleavage products are also substrates for further degra-
dation by the dual 59–39 exo and endo activities of the
enzyme (Fig. 4).
DNase activity of UL12 mutant proteins
In vitro analysis of the activities of C-terminally trun-
cated proteins, including N577, revealed that deletion
of as few as 49 amino acids from the C-terminus of the
HSV-1 DNase completely abrogated enzyme activity.
By contrast, 126 residues could be removed from the
N-terminus with full retention of enzyme activity, as
determined by our in vitro assay. The latter results are
in excellent agreement with those of Bronstein et al.
(1997). These investigators showed that protein puri-
fied from cells infected with viral mutant AN-F1, des-
ignated UL12.5 and predicted to encode residues 127–
626 from a promoter downstream of the endogenous
UL12 promoter, possessed the same specific activity
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as the wild-type enzyme. Thus, UL12 residues 127–626
are necessary and sufficient for fully functional en-
zyme activity. Nevertheless, removal of only 22 addi-
tional residues from the N-terminus resulted in com-
plete loss of enzymatic activity.
The importance of the C-terminus for the function of
the DNase is suggested by the relatively high conserva-
tion of this region first noted among HSV-1, HSV-2, and
EBV (Draper et al., 1986; McGeoch et al., 1986) and
extended through sequence comparisons of up to 14
herpesvirus homologs (Martinez et al., 1996a, and our
unpublished results). Clear divergence, as previously
noted by others (McGeoch et al., 1986), is evident in the
first 126 residues, with homologies found only between
HSV-1 and HSV-2 in this region. That the HSV-1 protein
lacking these residues possesses wild-type enzymatic
activity in vitro is not surprising given that enzymatic
activity has been detected in the other homologs lacking
this region, particularly in the EBV DNase homolog which
has been expressed in E. coli (Lin et al., 1994). In agree-
ment with our results demonstrating the importance of
HSV-1 residues just downstream of 126, these latter
authors found several mutations in the N-terminal region
of EBV which abolished activity. It is interesting to note
that these authors found that a mutation of EBV leucine
23 (to glycine), which corresponds to HSV-1 leucine 150
by multiple sequence alignment (results not shown),
completely abrogated enzyme activity in vitro (Lin et al.,
1994). Likewise, we found that a nonconservative muta-
tion (L to K) of HSV-1 residue 150 destroyed activity,
though a conservative mutation at the same site did not
(Table 2).
Function of DNase mutant proteins in virus
replication
In order to correlate the enzymatic activity of the
DNase mutant proteins with their respective abilities to
function in the replication of the virus, we determined
their abilities to complement the productive replication of
AN-1. Deletion of the DNase gene in this mutant does not
completely prevent the production of infectious virions.
However, it does reduce the yield by at least 3 orders of
magnitude compared to the wild-type virus and has a
profound effect on the ability of the virus to form plaques
in ‘‘nonpermissive’’ Vero cells (Weller et al., 1990). Trans-
fection of nonpermissive cells with plasmids which ex-
press the wild-type UL12 gene complemented the repli-
cation defect of AN-1, as demonstrated by 12-fold in-
creases in virus yields compared to those produced in
cells transfected with vector alone. Though not all plas-
mids enhanced the replication of AN-1 as well as the
wild-type plasmid, all mutations which retained HSV-1
DNase activity were capable of significantly enhancing
the replication of AN-1 compared to empty vector alone.
Those plasmids encoding proteins lacking HSV-1 DNase
activity in vitro (d2-148, L150K, N577) also failed to en-
hance the production of infectious virions by AN-1 (Table
2). Thus there is a strong correlation between the ability
of the protein encoded by UL12 to function as a nuclease
in vitro and its ability to function in the productive repli-
cation cycle of the virus.
We found that enhancement of replication by the d1-
126 plasmid was significantly less than that for wild-type
plasmid in six of six experiments (Fig. 6 and Table 2),
despite the fact that the enzymatic activity specified by
this mutant protein was qualitatively and quantitatively
indistinguishable from the wild-type enzyme in vitro
(Figs. 4 and 5). It was possible that the large deletion in
the d1-126 mutant protein resulted in poor availability
due to lack of or inefficient nuclear localization. We view
this possibility as unlikely because even in the absence
of other HSV-1 proteins, the d1-126 protein localized
exclusively in the nuclear fraction of insect cells infected
with a d1-126 expressing baculovirus recombinant (re-
sults not shown). Although the exact specific activities of
the other active mutant proteins were not determined,
major differences were not likely, since we observed no
difference in cleavage pattern, compared to the wild-type
protein, for the same dilutions of translation product. We
also think it unlikely that the point mutations cause a
disruption in nuclear localization, since none of these
mutations occur in regions of the gene which contain a
strong match to known nuclear localization signals (un-
published results). We cannot rule out the possibility that
overall tertiary structure is altered significantly enough to
affect nuclear localization, though such major conforma-
tional alterations should have affected the ability of these
proteins to cleave DNA in vitro.
There also is the possibility that the mutated or de-
leted sequences may be important for a function of the
protein which is unrelated to its ability to function as a
nuclease intracellularly. Though our results do not com-
pletely exclude this possibility, the strong correlation we
have found between the ability of a mutant protein to
function in vitro and its ability to function at least partially
in virus replication suggests that it is the enzyme activity
of the UL12 protein per se which is required for efficient
production and egress of infectious progeny virus.
Although we have been unable to confirm that all of
the mutant proteins expressed alone are able to enter
the nucleus, those with complementing activity must be
able to do so in the presence of other viral proteins in the
infected cell, since complementation would require ac-
cess of the mutant proteins to the nucleus. Indeed, a
protein equivalent to d1-126 (UL12.5) is expressed by the
mutant virus AN-F1 and is found tightly associated with
capsids derived from the nucleus (Bronstein et al., 1997).
In contrast to our results which indicate that d1-126
protein can function in viral replication, albeit poorly, the
latter authors found the AN-F1 mutant to be as deficient
in replication as the null mutant, AN-1 (Martinez et al.,
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1996b). The difference noted in the ability of d1-126 to
function in replication could reflect differences in its
expression level from a viral genome vs its expression
from a plasmid during transient complementation. Al-
though we have demonstrated that at least 70% of d1-126
expressed by in vitro transcription/translation is soluble,
we cannot exclude the possibility that the level of ex-
pression of the protein in transient complementation
assays could result in lower relative solubility of the
protein compared to the wild-type protein. High-level
expression of a protein could induce precipitation, could
cause the protein to localize improperly, or could result in
altered stoichiometry of that protein with other partners,
thereby interfering with function. It is interesting to note
that the N-terminal region is extremely proline rich—23%
of the first 126 residues are proline. Because proline-rich
regions have been implicated as motifs for protein–pro-
tein interactions, this region may form a stable contact
with other viral or cellular proteins to direct the DNase to
its proper site of function within the nucleus. Further
studies will be required to determine the impact and
significance of the association of d1-126 (UL12.5) with
capsids on its ability, or lack thereof, to facilitate the
maturation and egress of complete capsids.
MATERIALS AND METHODS
Growth of cells and virus
Baby hamster kidney (BHK) clone 13 and Vero cells
were propagated in Dulbecco’s modified minimum es-
sential medium (Flow Laboratories, McLean, VA) supple-
mented with 5 and 7.5% fetal bovine serum, respectively,
as previously described (Gallo et al., 1988). The 6-5 cell
line, a stable Vero transfectant carrying multiple copies
of the HSV-1 UL12 gene and fully permissive for the
replication of the UL12 mutant AN-1 (Shao et al., 1993),
was the kind gift of Sandra Weller (University of Connect-
icut, Farmington, CT). The 6-5 cell line was maintained in
the presence of 200 mg G418/ml.
The HSV-1 strain KOS (Smith, 1964) was used to pre-
pare purified DNase and as the source for plasmid
clones containing the DNase gene. For complementation
analysis, the UL12 null mutant AN-1 (Weller et al., 1990;
gift of Sandra Weller), which is deleted for most of the
UL12 gene, was used. Stocks of HSV-1 strain KOS were
prepared in Vero cells by low multiplicity passage (Parris
et al., 1978). Stocks of AN-1 were similarly prepared in
the permissive 6-5 cell line and assayed for replication
on both Vero and 6-5 cells.
Purification of the HSV-1 DNase
Nuclear lysates of HSV-1-infected BHK cells (approxi-
mately 1.3 3 109 cells), harvested at 18 h postinfection
(p.i.), were prepared as described previously (Gallo et al.,
1988). The DNase was separated from most of the other
proteins using fast protein liquid chromatography (FPLC)
through DEAE–Sephacel, blue Sepharose, and Pharma-
cia Mono Q (HR5/5) columns essentially as described
(Gallo et al., 1988). The purification of the DNase was
monitored by assay of fractions for exo activity and by
immunoblotting with an anti-peptide antibody (319A) as
described below. The DNase-containing fractions from
the Mono Q column were pooled and dialyzed at 4°C
overnight against buffer C containing 25 mM HEPES, pH
7.5, and 1 mg/ml each of leupeptin, aprotinin, pepstatin A,
and b-lactoglobulin. The dialyzed sample was loaded
onto a Pharmacia Mono S (HR 5/5) column, and the
protein eluted with a KCl gradient. Aliquots (250 ml) of
each fraction containing activity were stored at 220°C in
buffer containing 50% glycerol, 100 mM K2HPO4, pH 7.0,
10 mM 2-mercaptoethanol, 100 mg leupeptin/ml, and 100
mg aprotinin/ml.
Construction of plasmids and mutations
Plasmid pON114 (gift of Ed Mocarski, Stanford Univer-
sity), the source of DNA for the in vitro hypersensitivity
cleavage assay, contains a portion of the terminally re-
dundant ‘‘a’’ sequence from HSV-1 DNA, including the
cis-acting signals for cleavage and packaging of virion
DNA (Stow et al., 1983; Vlazny et al., 1982; Varmuza and
Smiley, 1985).
The HSV-1 DNase gene was subcloned into pUC 9 as
a 3.1-kbp HindIII to BamHI fragment from the plasmid
pSG 10 (Goldin et al., 1981) which was kindly provided by
Rozanne Sandri-Goldin (University of California, Irvine).
The gene was further subcloned into the phagemid vec-
tor pTZ 19U (U.S. Biochemical, Cleveland, OH) from the
BstEII site (converted to a HindIII site with linkers), lo-
cated 381 nucleotides upstream from the ORF, to the 39
BamHI site. The downstream BamHI site was destroyed
and converted to a HindIII site by addition of linkers.
Following cleavage with HindIII, the resulting 2.4-kbp
fragment was cloned into a pTZ 19U derivative lacking
the BamHI site in the polylinker. The resulting plasmid,
designated pTZ DN8, contained the wild-type DNase
gene downstream of the T7 RNA polymerase promoter
(Fig. 1). A derivative of this plasmid in which the 39 HindIII
site in the polylinker was destroyed to facilitate cloning
of mutated sequences was constructed by polymerase
chain reaction (PCR) of the C-terminal portion of the
DNase gene, yielding pTZDN8/HindIII2.
Diagrams of most of the mutations constructed are
shown in Fig. 1. C-terminal deletion mutations N179,
N374, N501, and N566 were generated by cleavage of
plasmid pTZ DN8 at the XhoI, NcoI, first BglII, and PvuI
sites, respectively, within the ORF prior to in vitro tran-
scription (see below). The N-terminal deletion mutations
were constructed using a two-step PCR approach to
separately amplify the sequences in pTZ DN8 upstream
and downstream of the deletion, followed by annealing
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and subsequent PCR amplification of the combined seg-
ments (Fig. 1). Amplified products were cleaved with
appropriate restriction enzymes as indicated in Table 1
and used to replace the corresponding wild-type frag-
ment in pTZDN8/HindIII2. Internal mutations were cre-
ated using either a one- or two-step PCR approach and
cloned as indicated in Table 1, with the exception of
d373-375, which resulted from a cloning artifact. All mu-
tations were confirmed by DNA sequencing.
In vitro transcription/translation
In most instances, plasmid DNA was linearized with
the appropriate restriction enzyme as indicated in Fig. 1,
and run-off transcripts were generated with T7 RNA
polymerase (Promega Biotec, Madison, WI) according to
the instructions of the manufacturer. Purified RNA tran-
scripts (0.05 to 0.10 mg) were translated in RRL (Promega
Biotec) for 1 h at 30°C according to the instructions of the
manufacturer. In some cases as indicated in the figure
legends, a coupled transcription/translation system was
used (Promega Biotec). Parallel samples to be analyzed
for protein content by SDS–PAGE contained 10 mCi
L-[35S]methionine (sp act, 1000–1200 Ci/mmol; Amer-
sham, Arlington Heights, IL).
Nuclease assays
Exo activity in column fractions was measured by the
release of trichloroacetic acid-soluble radioactivity from
bacterial DNA labeled in vivo with [14C]thymine accord-
ing to the procedure of Hoffmann and Cheng (1978).
For qualitative analysis of the HSV-1-specific DNase
activity, cleavage of the DNA substrate at hypersensitive
sites was analyzed by electrophoresis through sequenc-
ing gels. The assay employed the 176-bp HindIII/EcoRI
fragment from plasmid pON114, 39 end-labeled at
the HindIII site by incorporation of [a-32P]dATP and
[a-32P]dCTP using Klenow fragment. Reactions were per-
formed in a total volume of 25 ml at 37°C for the times
indicated in the figure legends. Reactions contained 50
mM Tris–HCl (pH 7.5), 5 mM MgCl2, 5 mM dithiothreitol,
and 150,000 cpm of DNA fragment, and were initiated
with 2 ml of purified nuclease or programmed RRL as
indicated. In some cases as indicated in the figure leg-
ends, reactions contained 10 mM EGTA to inhibit resid-
ual micrococcal nuclease activity in RRL. Reactions with
purified HSV-1 DNase were performed at 37°C and em-
ployed 10 units (1 unit was defined as the amount of
enzyme which hydrolyzed 1 ng of double-stranded DNA
to acid-soluble material in 15 min at 37°C), while those
containing DNase I (0.25–2.5 units, as defined by the
manufacturer; Bethesda Research Laboratories, Gaith-
ersburg, MD) were incubated at room temperature. Re-
actions were terminated by the addition of 2 mg tRNA as
carrier and EDTA to a final concentration of 20 mM. The
DNA was extracted and concentrated, and the cleavage
products were analyzed by electrophoresis through gels
containing 8.3 M urea and 6% polyacrylamide. The gel
was exposed to X-ray film at 280°C.
For quantitation of nuclease activity present in pro-
grammed RRL, we measured the activity as the loss of
full-length labeled DNA substrate. Following translation
in the presence of [35S]methionine, EGTA was added to
10 mM and RRL mixtures were incubated for 15 min at
0°C. The mixtures were diluted in reaction buffer and
incubated with end-labeled DNA substrate for 1–40 min,
and the products separated as described above. The
amount of uncleaved DNA substrate relative to total was
measured using a Molecular Dynamics PhosphorImager
(Model 445SI, Sunnyvale, CA). A 10-ml portion of each
diluted RRL mix was analyzed for protein content by
SDS–PAGE. To control for possible differences in protein
content, bands corresponding to the appropriate HSV
DNase polypeptides were quantified using a Phos-
phorImager and adjusted for methionine content.
Antibody preparation and immunoblotting
The synthetic peptide KTTSSSPTTGRSSR (Cambridge
Research Biochemicals, Atlantic Beach, NY) correspond-
ing to the 13 C-terminal amino acid residues of the
predicted DNase protein sequence linked to a lysine
residue was coupled via the lysine to bovine serum
albumin (BSA) and the mixture used to immunize rabbits,
as previously described (Parris et al., 1988). Serum was
adsorbed to a BSA–Sepharose column to remove the
BSA determinants and was designated 319A. To assay
column fractions for the presence of DNase, dot blots
were prepared by applying 50 ml of each fraction to
nitrocellulose (Schleicher & Schuell, Inc., Keene, NH)
using a vacuum manifold device. Proteins separated by
SDS–PAGE were electrophoretically transferred for 6 h at
450 mA to nitrocellulose as previously described (Towbin
et al., 1979). Nitrocellulose filters were blocked and
probed with antibody and 125I-labeled Staphylococcus
aureus protein A (sp act, 63 mCi/mg; ICN Biomedicals,
Inc., Irvine, CA) as described previously (Gallo et al.,
1988) and exposed to Kodak X-OMAT film at 280°C.
Complementation analysis
Plasmids containing wild-type and mutated HSV-1
UL12 genes were tested for their ability to complement
the replication of the UL12 null mutant AN-1, using a
modification of the assay previously described (Reddig
et al., 1994). Four replicate cultures of BHK cells, which
replicate the mutant poorly, were transfected with 10 mg
of plasmid using the CaPO4 method, superinfected with
AN-1 at an m.o.i. of 2.5 PFU/cell 25 h later, followed by an
acid–glycine wash to remove unadsorbed virions. At 18 h
p.i., cells were harvested and lysed by sonication, and
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the yield of progeny from each culture was determined
by plaque assay on permissive (6-5) and nonpermissive
(Vero) cells.
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